Procter & Gamble Health Ltd reported a sales drop of 5% to Rs277 crores and a profit before exceptional items of Rs43 crores for Q4 2024. For the fiscal year, total sales were Rs1129 crores, down 6% with a profit of Rs294 crores; the Board recommended a final dividend of Rs60 per equity share.